GE Healthcare has introduced Dynamic VUE, a new application for performing dynamic studies of the heart that can help cardiologists detect perfusion defects.
Available on Discovery Dimension Console on the Discovery STE and Discovery VCT, as well as the AW Workstation, physicians can perform qualitative analysis of the heart tissue to better determine the extent of disease and, therefore, select appropriate treatment options. Dynamic VUE will help enable cardiologists to determine the existence of underlying cardiovascular disease as well as quantify the level of disease in the coronary vessels.
“Recent studies have shown that perfusion studies and vessel analysis are a key indicator of cardiovascular disease,” said Hadi Moufarrej, global general manager of molecular imaging at GE Healthcare.
At the heart of Dynamic VUE is the capability to perform advanced dynamic studies, which allows clinicians to determine the degree of perfusion defects. Combined with the workflow efficient dynamic studies that can be performed on Discovery Dimension Console, Dynamic VUE facilitates the quantitative assessment of myocardial tissue.
Clinicians using Dynamic VUE can perform various analyses including summing over selected temporal windows, extracting multiple region of interests from which the time activity curves (TACs) can be extracted. Scaling and visualization of the activities and the exportability of TACs provide unique opportunities for further advanced analysis, which is valuable for early disease detection.
Dynamic VUE is a tool that assesses dynamic PET data shortly after it’s acquired, according to Tim Turkington, PET physicist, Duke University Medical Center.
The application can perform analyses of dynamic ECG—and also respiratory-gated studies. Dynamic VUE is also applicable to the analysis of brain tissue as well as tumor assessment where the data is acquired dynamically or respiratory-gated in oncology studies.